Fotemustine

DB04106InvestigationalSmall molecule

Fotemustine is an alkylating agent used in the treatment of metastatic melanoma. A cancer drug used to treat a type of skin cancer that has spread to other sites of the body.

Chemical structure of Fotemustine
Formula / weight
C9H19ClN3O5P · 315.69 g/mol (avg)
Also known as
(±)-DIETHYL (1-(3-(2-CHLOROETHYL)-3-NITROSOUREIDO)ETHYL)PHOSPHONATE · Mustoforan · PHOSPHONIC ACID, (1-((((2-CHLOROETHYL)NITROSOAMINO)CARBONYL)AMINO)ETHYL)-, DIETHYL ESTER · PHOSPHONIC ACID, P-(1-((((2-CHLOROETHYL)NITROSOAMINO)CARBONYL)AMINO)ETHYL)-, DIETHYL ESTER
Code names
S-10036 · Servier-10036

Resolves to

Compound
UNIIGQ7JL9P5I2CAS92118-27-9ChEMBLCHEMBL549386ChEBI131852PubChem46936889
Clinical / RWD
ATCL01AD05
Structure
InChIKeyYAKWPXVTIGTRJH-UHFFFAOYSA-NSMILESCCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O
Targets
Q16881TXNRD1

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
38Drug interactionsStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3Marketed productsAcross 3 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 6 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Fotemustine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In